This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
News Medical on MSN
Metabolic reprogramming drives prostate cancer progression and treatment resistance
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Foshan Ionova Biotherapeutics Co. Ltd. has described proteolysis targeting chimeras (PROTACs) comprising an E3 ubiquitin-protein ligase binding moiety covalently linked to an androgen receptor variant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results